OXBR exhibits severe financial distress, highlighted by a critical Piotroski F-Score of 1/9, indicating fundamental weakness across almost all health metrics. While the company shows strong top-line revenue growth of 36.5%, this is completely offset by catastrophic profitability, with a profit margin of -80.68% and an ROE of -41.19%. The stock is in a clear technical downtrend, losing over 51% of its value in the last year, and consistently misses earnings estimates by wide margins. Trading at a P/B of 0.95 suggests the market is pricing in the ongoing erosion of the company's book value.